Skip to content
Home/Companies/Biotech/Brink Therapeutics
Brink Therapeutics

Brink Therapeutics

Biotech·France·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Brink Therapeutics?

Brink Therapeutics is currently owned by Breega through Breega Seed fund (2023 vintage), since 2025.

Hand-verified · updated 2026-05-07

Breega
Investor
Breega
Breega Seed fund · 2023 · VC

Key facts

HQFrance
SectorBiotech
StatusActive
Websitewww.brinktx.com

More from Breega Seed fund

Other portfolio companies in the same fund.

BioOrbit
BioOrbit
Active
BiotechUK· 2026
Keith
Keith
Active
LegalTechUK· 2026
Quideos
Active
SaaSFrance· 2026
Edailabs
Active
EdTechFrance· 2025
Ensol
Active
ClimateTechFrance· 2025
Flow48
Flow48
Active
FintechUAE· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Brink Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Brink Therapeutics?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Brink Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue